NDC 29983-2712 - CALNATE-DMPK
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 29983-2712
- Package NDCs from labels
- 29983-2712-3
- Manufacturer
- IBA, Inc.
- Effective date
- 2018-04-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CMPK Solution | IBA, Inc. | 2018-04-30 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 29983-2712-3 | CALNATE-DMPK | 500 mL in 1 BOTTLE | SOLUTION | 500 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 29983-2712 | CALNATE-DMPK (CALCIUM PHOSPHORUS MAGNESIUM POTASSIUM DEXTROSE) SOLUTION [IBA, INC.] | 1 | 1 package rows | 20180430_53ce90f7-c054-4d9d-8bb9-18c4c47f8ab0.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CVS Health Ultra Strength Natural Antacid Peppermint Flavor | ANTACID TABLETS | CVS Pharmacy,Inc. | 4f18fd8d-4d6a-4b1d-8a94-b64592f73ad0 | 2025-08-13 | Warnings | H0G9379FGK |
| MGC Health Calcium Carbonate Antacid Assorted Berries | CALCIUM CARBONATE | Xiamen Kang Zhongyuan Biotechnology Co., Ltd. | b84d80c6-0240-4276-8e47-74a918f3d86a | 2025-08-12 | Warnings | H0G9379FGK |
| Embriva | ASCORBIC ACID, CHOLECALCIFEROL, THIAMINE, PYRIDOXAL PHOSPHATE, FOLIC ACID, METHYLCOBALAMIN, CALCIUM CARBONATE, FERROUS GLUCONATE, POTASSIUM IODIDE | Oncora Pharma, LLC | 3c362de4-1ed9-83be-e063-6394a90a10fc | 2025-08-12 | Warnings | H0G9379FGK |
| Potassium Chloride | POTASSIUM CHLORIDE | Henry Schein, Inc. | bf8e8ac7-e6a8-4571-a0ea-7bcab89290f6 | 2025-08-12 | Warnings, Adverse reactions | 660YQ98I10 |
| UP AND UP DUAL ACTION ACID REDUCER ANTACID | FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | Target Corporation | 8e925e57-9036-4658-bf07-578e22675af8 | 2025-08-11 | Warnings | H0G9379FGK |
| Acid Reducer Plus Antacid | FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE | CVS Pharmacy | d6f0b82c-3890-4e85-8b8a-354fb8d0b640 | 2025-08-11 | Warnings | H0G9379FGK |
| Acid Reducer Plus Antacid | FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | CVS Pharmacy | 509435e4-14fd-4e09-bdc1-ad295b46806b | 2025-08-11 | Warnings | H0G9379FGK |
| Potassium Chloride | POTASSIUM CHLORIDE | AvKARE | 3bdfced1-6e62-9e92-e063-6294a90a28aa | 2025-08-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride Extended-Release | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3be29fcc-765e-8653-e063-6394a90a59d5 | 2025-08-08 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Slate Run Pharmaceuticals, LLC | 94ae03cc-b620-0dbb-e053-2a95a90a922c | 2025-08-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Slate Run Pharmaceuticals, LLC | 0cc57ece-f15a-4160-a5ea-8d6fa9f9e754 | 2025-08-07 | Warnings, Adverse reactions | 660YQ98I10 |
| Antacid | CALCIUM CARBONATE | ProStat First Aid | 3bb49eb3-2eaa-af8d-e063-6294a90a4035 | 2025-08-06 | Warnings | H0G9379FGK |
| Potassium Chloride | POTASSIUM CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 47a87fb6-5e61-41c9-b759-10f7c74a67ce | 2025-08-05 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | American Health Packaging | 7956883f-0d31-4081-bbea-d9ea320a193b | 2025-08-04 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | Marlex Pharmaceuticals Inc | 3e78028d-21a0-ba0f-e063-6294a90aac49 | 2025-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride for Oral Solution | POTASSIUM CHLORIDE FOR ORAL SOLUTION | Marlex Pharmaceuticals, Inc. | 3e8a6f61-44eb-4b5a-e063-6294a90a4b1b | 2025-08-01 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE EXTENDED RELEASE | POTASSIUM CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 3b403d60-4246-d765-e063-6394a90a12e8 | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | A-S Medication Solutions | 162a8ab5-76cf-48fa-8487-7780ed65647e | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | A-S Medication Solutions | 14db14ba-fd0d-4b2a-9f1c-a62b3b82306f | 2025-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | bfc4224a-2fc9-4137-b4c6-9d2d6d948413 | 2025-07-30 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.